Paper · 41353232

A rapid method of evaluating cytotoxic drug efficacy using sub-cellular fluctuation imaging.

Rehnstrom H and 8 others. Sci Rep, 2025. Cited by 1 paper, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. A rapid method of evaluating cytotoxic drug efficacy using sub-cellular fluctuation imaging. Papers, record 41353232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41353232

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: A rapid method of evaluating cytotoxic drug efficacy using sub-cellular fluctuation imaging.; PubMed
Journal: Sci Rep; PubMed
Year: 2025; PubMed
Publication types: Journal Article; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/41353232/; PubMed
DOI: https://doi.org/10.1038/s41598-025-30295-9; PubMed
PMC: https://pmc.ncbi.nlm.nih.gov/articles/PMC12780189/; PubMed
The journal: https://conductscience.org/library/journal-index/101563288; PubMed
Citations, by iCite: 1; iCite
Revised in PubMed: 2026-01-10; PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename
1	Rehnstrom H	Henrik
2	Eley A	Arthur
3	Clayton NS	Natasha S
4	Plant G	Georgina
5	Oviedo-Chavez D	Diego
6	Ede B	Ben
7	Hill DJ	Darryl J
8	Ridley AJ	Anne J
9	Antognozzi M	Massimo

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Antineoplastic Agents	Major topic
Humans
Paclitaxel
Cell Survival
Staurosporine
Cell Line, Tumor
Drug Screening Assays, Antitumor
Caco-2 Cells
Neoplasms
A549 Cells

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References41

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

Order	PMID	Title	Journal	Year	In Papers	Source
1	27,446,672	Dynamic full field optical coherence tomography: subcellular metabolic contrast revealed in tissues by interferometric signals temporal analysis.	Biomed Opt Express	2016	https://conductscience.org/library/papers/27446672	PubMed
2	9,721,628	Modulation of human CACO-2 intestinal epithelial cell phenotype by protein kinase C inhibitors.	Cell Biol Int	1995	https://conductscience.org/library/papers/9721628	PubMed
3	20,161,834	In vitro viability and cytotoxicity testing and same-well multi-parametric combinations for high throughput screening.	Curr Chem Genomics	2009	https://conductscience.org/library/papers/20161834	PubMed
4	11,245,486	Overexpression of BCL-X(L) underlies the molecular basis for resistance to staurosporine-induced apoptosis in PC-3 cells.	Cancer Res	2001	https://conductscience.org/library/papers/11245486	PubMed
5	73,185	Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by using glyoxal and acridine orange.	Proc Natl Acad Sci U S A	1977	https://conductscience.org/library/papers/73185	PubMed
6	12,036,415	Paclitaxel in cancer therapy.	Expert Opin Pharmacother	2002	https://conductscience.org/library/papers/12036415	PubMed
7	11,909,872	Bax-mediated Ca2+ mobilization promotes cytochrome c release during apoptosis.	J Biol Chem	2002	https://conductscience.org/library/papers/11909872	PubMed
8	2,464,289	Fluorometric assay of DNA in cartilage explants using Hoechst 33258.	Anal Biochem	1988	https://conductscience.org/library/papers/2464289	PubMed
9	25,064,821	Plasmonic imaging of protein interactions with single bacterial cells.	Biosens Bioelectron	2015	https://conductscience.org/library/papers/25064821	PubMed
10	22,028,621	Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells.	Neoplasia	2011	https://conductscience.org/library/papers/22028621	PubMed

1 to 10 of 41

See all 41 references

Cited by0

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

None in this release.

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41353232

GET https://conductscience.org/api/papers/v1/41353232/references?page=2

API reference For AI assistants